LinkedInXFacebook
Subscribe
Orthopedics This Week
  • My Feed
  • |Posts
  • |Events
  • |MSK Innovations
  • |Power Rankings
  • |Masterclasses
  • |Technology Awards
  • Press Releases
  • |Advertising
  • |Job Board
  • Spine
  • ◆Joints
  • ◆Upper Extremities
  • ◆Foot & Ankle
  • ◆Sports Medicine
  • ◆Pain Mgmt
  • ◆Trauma
  • ◆Biologics
  • ◆Technology
  • ◆People
  • ◆Company News
  • ◆Legal & Regulatory
Home/Legal & Regulatory and Reimbursement/Grassley Demands Medicare Advantage Investigation
Legal & Regulatory and Reimbursement

Grassley Demands Medicare Advantage Investigation

June 5, 2015 2 min read Premium comments

Advertisement

Grassley Demands Medicare Advantage Investigation
Senator Charles Grassley / Source: U.S. Senate and Medicare.gov
Secondary

Senator Charles Grassley is turning his investigative attention to alleged fraud in the Medicare Advantage (MA) program. The program is a kind of private Medicare for about 16 million elderly beneficiaries paid for by Medicare and run by private insurers.

Grassley, a co-father of the Sunshine Act, recently sent letters to CMS (Centers for Medicare and Medicaid Services) and DOJ (Department of Justice) regarding allegations of “Risk Score” fraud by the private MA insurers. Another Senator, Claire McCaskill, sent a similar letter to CMS asking what steps the agency was taking to address alleged Medicare Advantage fraud and abuse.

“Risk Score” is a formula based on a beneficiary’s health that lets CMS figure out what fee to pay private insurers each month per beneficiary. The higher the risk, the higher the payments. There have been recent allegations in False Claims whistleblower lawsuits that insurers like Aetna, Cigna, UnitedHealthCare and others have been fraudulently inflating risk scores.

$70 Billion Improper Payment Estimate

Here’s an example provided by our colleagues at Policy and Medicine. If a physician documents that a patient is drug or alcohol dependent, the government pays the plan $2, 400 extra for the added risk and associated anticipated expense. A recent article from The Center for Public Integrity said that when a home visit “unearths a medical condition, as it often does, health plans may be able to raise a person’s risk score and collect thousands of dollars in added Medicare revenue over a year—even if they don’t incur any added expenses caring for that person.” The Government Accounting Office has estimated that Medicare made $12 billion in improper payments to private insurers in 2014 for the MA program and nearly $70 billion from 2008 through 2013, based on inflated risk scores.

Fed Cover Up?

But, allegedly, the government already knew this.

Back in March 2015, the Financial Times reported that a study commissioned by the federal government in 2009 concluded that MA programs were overcharging. “However, ” stated the report, “the study was mysteriously never published, ” until it was unearthed by the Center for Public Integrity through a Freedom of Information Act request.

Advertisement

McCaskill, a Democrat, wrote that, “With fraudulently inflated risk scores potentially costing taxpayers billions of dollars every year and resulting in less money in the Medicare Trust Funds for our seniors, this is an issue that must be investigated further.” Grassley, a Republican, wants to know what approach DOJ and CMS are using to fight Medicare Advantage fraud. The DOJ is reportedly investigation the whistleblower’s false claims charges.

“With the reported increase in risk score gaming, and the monumental cost that the taxpayer will shoulder for such wrongdoing, it is imperative that CMS implement safeguards to reduce risk score fraud, waste and abuse. Moreover, if the reports of abuse are true, CMS should increase its auditing practices, ” Grassley wrote.

Neither CMS nor the Justice Department has commented on the letters.

React:

Discussion

14
DS
Dr. Sarah MitchellOrthopedic Surgeon · Mayo Clinic

This is a fascinating development. In my practice we've seen similar outcomes with the revised protocol. The key differentiator seems to be patient selection criteria. Has anyone else noticed the correlation with BMI thresholds?

8
JT
James Thornton, MDSpine Fellow · HSS

Great point. I'd push back slightly on the conclusion, the sample size in the cited study is too small to draw population-level inferences. That said, the directional signal is compelling and worth a larger RCT.

5
RP
R. PatelSports Medicine · Stanford

We implemented a similar approach last year. Early results are promising but we're still gathering 12-month follow-up data. Happy to share our protocol if anyone is interested.

Join the conversation

Orthopedic professionals are discussing this. Sign in and upgrade to read every comment and add your voice.

Subscribe

Get Full Access

Read every OTW article and join member discussions for $24.99/month.

Get Full Access

Advertisement

Advertisement

Advertisement

Orthopedics This Week

The most trusted source in orthopedic industry news since 2005. Covering spine, joints, trauma, biologics, and the business of orthopedics.

A publication of RRY Publications, LLC

LinkedInXFacebook

Categories

  • Spine
  • Joints
  • Upper Extremities
  • Foot & Ankle
  • Sports Medicine
  • Pain Mgmt
  • Trauma
  • Biologics
  • Technology
  • People
  • Company News
  • Legal & Regulatory

Resources

  • Subscribe
  • Community Posts
  • Job Board
  • Press Release Opportunities
  • Power Rankings
  • About OTW
  • Advertise
  • Contact Us

Get Full Access

Unlimited articles, community posts, and Power Rankings.

Get Full Access

Plans start at $24.99/mo · Annual saves 20%

© 2026 Orthopedics This Week · RRY Publications, LLC

Privacy PolicyTerms of ServiceCookie Policy